文献速递头颈部肿瘤放疗放疗物理与技术

保留CT值的双向循环GAN用于头颈放疗计划CT的对比剂添加与去除:多中心回顾性队列研究

CT number-preserving bidirectional cycle GAN for contrast addition and removal in head-and-neck radiotherapy planning CT: A multicenter retrospective cohort study.
PubMed 文献 · Radiother Oncol · 2026-07-10

该多中心回顾性研究提出BiHU-GAN,在头颈放疗中实现非增强CT(NCCT)与增强CT(CECT)的双向合成,内部606对(118,779层)训练并外部验证140对。合成CECT支持靶区勾画,合成NCCT保留CT值精度并维持剂量计算准确性,多数图像获临床可用评分。

要点

  • BiHU-GAN双向合成NCCT与CECT,保留CT值并增强低对比特征。
  • 合成CECT与参考勾画一致性高,支持淋巴结靶区勾画。
  • 合成NCCT剂量计算与NCCT无显著差异,gamma通过率≥95%。

核心结论

  • BiHU-GAN生成解剖保真且CT值准确的合成图像,合成CECT改善勾画,合成NCCT保持剂量精度。

研究设计与样本

  • 多中心回顾性队列研究,内部606对头颈NCCT/CECT(118,779层),外部验证140对来自SegRap2023/2025。
  • 采用标准图像质量评估与盲法5分临床评分,并评估勾画一致性与剂量计算准确性。

主要发现

  • BiHU-GAN优于所有对比方法,合成CECT在结构相似性和CT值保真度上接近CECT。
  • 至少85%合成图像获临床可用评分(4或5分),内部队列达96%。
  • 合成NCCT全局CT值平均绝对偏差≤5.5 HU,89%-95%获临床可用评分。
  • 合成NCCT剂量计算在DVH终点及2%/2 mm、3%/3 mm gamma通过率(≥95%)与NCCT无显著差异。
  • 直接在CECT上剂量计算出现更大系统性剂量偏差和更低gamma通过率。

关键数值与推荐

  • 临床可用定义为5分临床评分系统中评分4或5分。
  • 合成NCCT的CT值全局平均绝对偏差≤5.5 HU。
  • 剂量计算gamma通过率在2%/2 mm和3%/3 mm标准下≥95%。

临床怎么用

  • 可用合成CECT替代增强扫描辅助靶区勾画,减少对比剂使用和额外扫描。
  • 可用合成NCCT进行放疗剂量计算,避免直接使用CECT带来的剂量偏差。
  • 适用于对比剂禁忌或资源有限机构,多中心性能支持推广。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We propose a CT number-preserving bidirectional cycle generative adversarial network (BiHU-GAN) for two-way synthesis between non-contrast CT (NCCT) and contrast-enhanced CT (CECT) in head-and-neck radiotherapy, aiming to generate synthetic CECT (sCECT) from NCCT to improve target delineation, and synthetic NCCT (sNCCT) from CECT to enable accurate dose calculation. METHODS AND MATERIALS: BiHU-GAN integrates an explicit CT number deviation loss (enforcing CT number fidelity), a gradient-consistency loss (preserving structural edges), and a convolutional block attention module (CBAM)for low-contrast feature enhancement. Experiments were conducted on 606 paired head-and-neck NCCT/CECT cases (118,779 slices) from our institution and externally validated on 140 paired cases from SegRap2023/2025. We benchmarked against recent state-of-the-art methods using standard image-quality assessments and blinded 5-point clinical scoring. In addition, we assessed contouring consistency to validate sCECT for target delineation, and dose calculation accuracy to verify sNCCT for radiotherapy dose calculation. RESULTS: BiHU-GAN outperformed all other methods. sCECT closely matched the CECT in structural similarity and CT number fidelity, supporting reliable nodal target delineation, with high contour agreement to references. At least 85% of synthetic images were rated clinically usable (score 4 or 5 on the 5‑point clinical scoring system), reaching 96% in the internal cohort. sNCCT maintained excellent CT number accuracy (with a global mean absolute deviation of CT numbers ≤ 5.5 Hounsfield units) and high clinical acceptability, with 89%-95% clinically usable ratings. Dose calculations on sNCCT showed no significant differences from NCCT in dose-volume histogram endpoints or 3D gamma pass rates at the 2%/2 mm and 3%/3 mm criteria (gamma pass rates ≥ 95%). By contrast, direct dose calculation on CECT yielded larger systematic dose deviations and lower gamma pass rates. CONCLUSIONS: BiHU-GAN generates anatomically faithful and CT number-accurate synthetic images-improving delineation via sCECT while preserving dose accuracy via sNCCT. It avoids contrast and extra scans, reduces patient burden, and suits contrast-contraindicated or resource-limited settings. Robust multicenter performance supports broad clinical adoption.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Lin J, Xu Z, Lü Y, et al. CT number-preserving bidirectional cycle GAN for contrast addition and removal in head-and-neck radiotherapy planning CT: A multicenter retrospective cohort study. Radiother Oncol. 2026. PMID: 42431269. doi:10.1016/j.radonc.2026.111691

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。